In conclusion, the central role of ARID1A in the maintenance of epithelial cell identity indicates a strong potential for the therapeutic targeting of epigenetic mechanisms and chromatin accessibility for the reduction of cancer risk and tumorigenic transformation. This evidence concerns the gene ARID1A and cancer.